Search Results for keywords:"epilepsy"

The Federal Motor Carrier Safety Administration (FMCSA) has renewed exemptions for seven drivers who have epilepsy or seizure disorders, allowing them to continue driving commercial motor vehicles across state lines. These exemptions, effective from August 31, 2024, to August 31, 2026, were granted after the FMCSA determined that they would maintain or exceed safety standards for drivers. Despite public invitations for comments, no feedback was received during the review periods. Each exemption will last two years unless revoked due to non-compliance, decreased safety, or inconsistency with regulatory goals.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for 10 individuals who have a history of epilepsy or seizures. Normally, drivers with such medical history are not allowed to operate commercial motor vehicles (CMVs) in interstate commerce due to safety regulations. However, these exemptions allow the individuals to continue driving as long as they are on anti-seizure medication, ensuring safety is equivalent to standard regulations. The exemptions are valid for two years from their effective date but can be revoked if safety conditions are not met.

The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation, is considering granting exemptions for 32 individuals who have a history of epilepsy or seizure disorders, allowing them to drive commercial motor vehicles across state lines. These individuals are currently taking medication and have been seizure-free for a significant period. FMCSA requests public comments on these exemption requests to ensure they meet safety requirements and provide an equivalent or higher level of safety than current regulations. The agency will review each applicant’s medical history and driving record before deciding.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for eight individuals, allowing them to continue driving commercial motor vehicles despite having epilepsy or a history of seizures. These individuals are taking medication for their condition, and FMCSA has determined that the exemptions provide a safety level equal to or greater than the standard regulations. The exemptions are valid for two years, and can be revoked if safety conditions are not met.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for ten individuals, allowing them to drive commercial motor vehicles even though they have epilepsy or seizure disorders, as long as they remain seizure-free and under stable treatment. These exemptions are valid for two years and enable the individuals, who are on anti-seizure medication, to continue working in interstate commerce. FMCSA ensures ongoing safety through annual medical reports and examinations, and while the exemption is in effect, states cannot enforce conflicting laws against these drivers. If any conditions are not met or if safety is compromised, the exemptions can be revoked.

The Centers for Disease Control and Prevention (CDC) has announced a closed meeting scheduled for March 19, 2025. This meeting, which will be conducted via teleconference, will focus on reviewing and evaluating grant applications related to the incidence of epilepsy among children in the United States. The meeting is closed to the public due to the discussion of confidential information such as trade secrets and personal information. Dr. Catherine Barrett is the contact person for further information regarding the meeting.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to grant exemptions to three individuals with epilepsy or seizure disorders, allowing them to operate commercial motor vehicles across state lines. This decision, effective from January 11, 2021, until January 11, 2023, was based on each individual's medical history and stable treatment regimen. The individuals granted these exemptions have been seizure-free for many years while on medication. The FMCSA believes that this exemption ensures a safety level similar to, or better than, what the standard regulations would achieve.

The Federal Motor Carrier Safety Administration (FMCSA) has received applications from 12 individuals seeking exemptions from a rule that generally prohibits people with epilepsy or related conditions from driving commercial motor vehicles (CMVs) in interstate commerce. These individuals, who have had seizures but are currently under medication and seizure-free, want to be allowed to drive CMVs. The FMCSA is evaluating their qualifications and inviting public comments on these exemption requests by January 27, 2025. This notice reflects ongoing efforts to balance regulatory safety standards with opportunities for drivers managing medical conditions to legally operate CMVs.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for eight individuals from the rules that usually require interstate commercial motor vehicle (CMV) drivers to have no history or diagnosis of epilepsy or conditions causing loss of consciousness. These exemptions allow drivers who have had seizures but are managing their condition with medication to continue operating CMVs. The renewed exemptions last for two years, provided that the drivers remain seizure-free and adhere to specific regulations. The FMCSA encourages the public to comment on this decision before the specified date, particularly if there are concerns about the drivers' safety records.

The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation (DOT), has announced a decision to renew a specific medical exemption for 10 truck drivers who have epilepsy or a history of seizures. These drivers, who take anti-seizure medication, are allowed to continue driving commercial vehicles across state lines. FMCSA found that renewing these exemptions maintains or improves safety levels compared to standard regulations. The exemptions are valid for two years unless revoked earlier based on specific conditions not being met.